Home Cart 0 Sign in  
X

[ CAS No. 3788-94-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3788-94-1
Chemical Structure| 3788-94-1
Chemical Structure| 3788-94-1
Structure of 3788-94-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3788-94-1 ]

Related Doc. of [ 3788-94-1 ]

Alternatived Products of [ 3788-94-1 ]

Product Details of [ 3788-94-1 ]

CAS No. :3788-94-1 MDL No. :MFCD06797311
Formula : C9H14O4 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 186.21 Pubchem ID :-
Synonyms :

Safety of [ 3788-94-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H227-H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3788-94-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3788-94-1 ]
  • Downstream synthetic route of [ 3788-94-1 ]

[ 3788-94-1 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 3788-94-1 ]
  • [ 85290-78-4 ]
Reference: [1] Molecules, 2015, vol. 20, # 3, p. 4383 - 4394
  • 2
  • [ 3788-94-1 ]
  • [ 42831-50-5 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 1875 - 1880
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
[3] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 23, p. 502
  • 3
  • [ 3788-94-1 ]
  • [ 51135-73-0 ]
YieldReaction ConditionsOperation in experiment
79% With hydroxylamine In methanol; water at -5 - 30℃; for 2.5 h; Heating / reflux Ethyl-5-methylisoxazole-4-carboxylate:Ethyl ethoxymethyleneacetoacetate, 110.00 g (0.59 mol) was taken in methanol (330 ml) and cooled to -5 0C and 50percent aqueous hydroxyl amine 39.03 g (0.59 mol on anhydrous basis) was added drop wise over a period of 1 hour at -5 to O0C. It was stirred for 30 minutes. The reaction mixture was allowed to attain temperature of 20 to 30 0C and then refluxed for 1 S hour. Solvent was removed under reduced pressure and the reaction mass was cooled to room temperature. n-Hexane (500 ml) was added and stirred for 30 minutes. Saturated sodium bicarbonate solution (100 ml) was added followed by water (400 ml) and stirred well. The organic layer was separated. The aqueous layer was re-extracted with n-hexane (2x200 ml). The combined organic layer was washed with water (2x250 ml). After removal of the solvent <n="8"/>72.5 g (79percent) of Ethyl-5-methylisoxazole-4-carboxylate was obtained as yellowish thick oil with 98.7 percent HPLC purity and having isomeric impurity less than 0.5 percent.
78% With hydroxylamine hydrochloride; sodium acetate In methanol; water at 0 - 20℃; Solution of hydroxylamine hydrochloride (4.1 g, 0.059 mol) and sodium acetate (4.84 g, 0.059 mol) in water (10 ml) was added dropwise to a solution of compound 3 (11 g, 0.059 mol) in methanol (25 ml) at 0 °C. The mixture was stirred during overnight at room temperature followed by extraction with EtOAc (3 x 50 ml), the combined EtOAc extract was washed by aqueous sodium bicarbonate solution to minimize the impurities and dried over Na2SO4. After that the solvent was removed to afford 7.16 g (78 percent) of Ethyl-5-methylisoxazole-4-carboxylate as yellow oil, which was used directly in the next step.
Reference: [1] Patent: WO2007/86076, 2007, A2, . Location in patent: Page/Page column 5-7
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 1875 - 1880
[4] Asian Journal of Chemistry, 2010, vol. 22, # 2, p. 1503 - 1506
  • 4
  • [ 141-97-9 ]
  • [ 122-51-0 ]
  • [ 3788-94-1 ]
YieldReaction ConditionsOperation in experiment
80% at 130℃; for 5 h; 2.22 Example 22 {prepared via Scheme 12)- 6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl)methyl]-2-(3-methoxyazetidin-l- yl)-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-5-one . iStep a) Intermediate 25Ethyl 2-(ethoxymethylene)-3-oxobutanoate A solution of ethyl 3-oxobutanoate (20 g, 154 mmol), triethylorthoformate (51.1 ml, 307 mmol), and acetic anhydride (43.5 ml, 461 mmol) was heated at 130 °C for 5 h. The reaction was cooled to r.t. and concentrated under reduced pressure to remove triethyl orthoformate and acetic anhydride. The remainder of acetic anhydride and triethyl orthoformate was removed by distillation (30 mbar, 30-70 °C). Ethyl 2-(ethoxymethylene)-3-oxobutanoate was distilled off (6 mbar, 80 °C to 128 °C) to leave ethyl 2-(ethoxymethylene)-3-oxobutanoate as a viscous yellow oil (22.8 g, 80percent) NMR (400 MHz, CDC13) δ 7.59 - 7.69 (m, 1H), 4.17 - 4.34 (m, 4H), 2.29 - 2.44 (m, 3H), 1.25 - 1.44 (m, 6H).
79% at 130℃; for 12 h; Ethylacetoacetate (15.62 g, 0.12mol), triethylorthoformate (17.78 g, 0.12 mol), acetic anhydride (28.82 g, 0.24 mol) were mixed and heated at 130 oC for 12 hr with stirring. The product was distilled to obtain 11.4 g (79 percent) of black oil that was used directly in the next step.
70% at 135℃; A mixture of ethyl acetoacetate (100 g, 0.77 mol), friethyi orthoformate ( 130 g, 0.92 mol), and acetic anhydride ( 150 g, 1 .5 mol) was heated ai 135 °C for 6 - 18 h in a round bottomed flask that was equipped with a distillation apparatus to collect the ethanol generated during the reaction. The reaction was cooled, concentrated and the residue was distilled under high vacuum to obtain the desired product (100 g, 70percent) as a pale yellow oil: ES MS m /z 181 [M + H]+.
65% at 130℃; for 4 h; A mixture of compound 1 (10.41 g, 0.08 mol), triethyl orthoformate (14.23 g, 0.10 mol) and acetic anhydride (20.42 g, 0.20 mol) was heated at 130 °C for 4 h.
The resulting EtOH, CH3CO2CH2CH3 and remaining materials were eliminated under reduced pressure and compound 2 (9.68 g) was obtained in 65percent yield.

Reference: [1] Journal of Heterocyclic Chemistry, 2018, vol. 55, # 4, p. 946 - 950
[2] Mendeleev Communications, 2016, vol. 26, # 1, p. 54 - 56
[3] Patent: WO2011/83316, 2011, A1, . Location in patent: Page/Page column 52-53
[4] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3563 - 3567
[6] Patent: WO2013/109388, 2013, A2, . Location in patent: Page/Page column 141
[7] Journal of medicinal chemistry, 2000, vol. 43, # 21, p. 3995 - 4004
[8] European Journal of Medicinal Chemistry, 2016, vol. 124, p. 935 - 945
[9] Heterocycles, 2004, vol. 64, p. 177 - 191
[10] Journal of the American Chemical Society, 1952, vol. 74, p. 4889
[11] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1979, p. 464 - 471

[12] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 1875 - 1880
[13] Journal of Medicinal Chemistry, 1992, vol. 35, # 18, p. 3413 - 3422
[14] Journal of Medicinal Chemistry, 2005, vol. 48, # 4, p. 1229 - 1236
[15] Patent: US2005/96353, 2005, A1, . Location in patent: Page/Page column 21
[16] Patent: US2006/30708, 2006, A1, . Location in patent: Page/Page column 10-11
[17] Tetrahedron, 2013, vol. 69, # 40, p. 8564 - 8571
[18] Russian Journal of General Chemistry, 2013, vol. 83, # 7, p. 1330 - 1335[19] Zh. Obshch. Khim., 2013, vol. 83, # 7, p. 1330 - 1335
[20] Russian Journal of Organic Chemistry, 2017, vol. 53, # 3, p. 381 - 392[21] Zh. Org. Khim., 2017, vol. 53, # 3, p. 384 - 394,11
[22] Molecules, 2015, vol. 20, # 3, p. 4383 - 4394
[23] Journal of Medicinal Chemistry, 2016, vol. 59, # 10, p. 4488 - 4510
[24] Patent: CN106212482, 2016, A, . Location in patent: Paragraph 0031; 0032
[25] Patent: CN106135228, 2016, A, . Location in patent: Paragraph 0027-0029
[26] Patent: CN106243101, 2016, A, . Location in patent: Paragraph 0027; 0028
  • 5
  • [ 141-97-9 ]
  • [ 149-73-5 ]
  • [ 3788-94-1 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 7, p. 1143 - 1146
  • 6
  • [ 141-97-9 ]
  • [ 3788-94-1 ]
Reference: [1] Organic Letters, 2009, vol. 11, # 17, p. 3934 - 3937
  • 7
  • [ 105-45-3 ]
  • [ 122-51-0 ]
  • [ 3788-94-1 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 46, p. 16458 - 16461
  • 8
  • [ 108-24-7 ]
  • [ 141-97-9 ]
  • [ 122-51-0 ]
  • [ 3788-94-1 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1897, vol. 297, p. 18
[2] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 4, p. 1311
[3] Justus Liebigs Annalen der Chemie, 1897, vol. 297, p. 18
[4] Chemische Berichte, 28 Ref. &lt;1895&gt;, 82,
[5] Patent: DE77354, , ,
[6] Patent: DE77354, , ,
  • 9
  • [ 75-03-6 ]
  • [ 3788-94-1 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1897, vol. 297, p. 57[2] Chemische Berichte, 1893, vol. 26, p. 2731
  • 10
  • [ 14036-06-7 ]
  • [ 141-97-9 ]
  • [ 3788-94-1 ]
Reference: [1] Journal of Organic Chemistry, 1937, vol. 2, p. 263
  • 11
  • [ 33142-24-4 ]
  • [ 122-51-0 ]
  • [ 3788-94-1 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1897, vol. 297, p. 57[2] Chemische Berichte, 1893, vol. 26, p. 2731
  • 12
  • [ 108-86-1 ]
  • [ 3788-94-1 ]
  • [ 620-80-4 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1969, vol. 42, p. 2991 - 2993
  • 13
  • [ 3788-94-1 ]
  • [ 78703-53-4 ]
Reference: [1] Molecules, 2015, vol. 20, # 3, p. 4383 - 4394
[2] Journal of Heterocyclic Chemistry, 2018, vol. 55, # 4, p. 946 - 950
  • 14
  • [ 3788-94-1 ]
  • [ 111493-74-4 ]
Reference: [1] Patent: WO2015/97658, 2015, A1, . Location in patent: Page/Page column 19; 20
  • 15
  • [ 3473-63-0 ]
  • [ 3788-94-1 ]
  • [ 110960-73-1 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1987, # 2, p. 318 - 324
  • 16
  • [ 3788-94-1 ]
  • [ 306960-74-7 ]
Reference: [1] Journal of medicinal chemistry, 2000, vol. 43, # 21, p. 3995 - 4004
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 3788-94-1 ]

Teriflunomide Related Intermediates

Chemical Structure| 455-24-3

[ 455-24-3 ]

4-(Trifluoromethyl)benzoic acid

Chemical Structure| 42831-50-5

[ 42831-50-5 ]

5-Methylisoxazole-4-carboxylic acid

Chemical Structure| 24522-30-3

[ 24522-30-3 ]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Chemical Structure| 51135-73-0

[ 51135-73-0 ]

Ethyl 5-methylisoxazole-4-carboxylate

Chemical Structure| 75706-12-6

[ 75706-12-6 ]

5-Methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide

Related Functional Groups of
[ 3788-94-1 ]

Alkenes

Chemical Structure| 87-13-8

[ 87-13-8 ]

Diethyl 2-(ethoxymethylene)malonate

Similarity: 0.80

Chemical Structure| 3044-06-2

[ 3044-06-2 ]

Diethyl 2-(1-ethoxyethylidene)malonate

Similarity: 0.71

Chemical Structure| 42466-67-1

[ 42466-67-1 ]

(E)-Ethyl 2-cyano-3-ethoxyacrylate

Similarity: 0.67

Chemical Structure| 94-05-3

[ 94-05-3 ]

Ethyl (ethoxymethylene)cyanoacetate

Similarity: 0.67

Chemical Structure| 108384-35-6

[ 108384-35-6 ]

Methyl 3-oxocyclopent-1-enecarboxylate

Similarity: 0.65

Aliphatic Chain Hydrocarbons

Chemical Structure| 87-13-8

[ 87-13-8 ]

Diethyl 2-(ethoxymethylene)malonate

Similarity: 0.80

Chemical Structure| 3044-06-2

[ 3044-06-2 ]

Diethyl 2-(1-ethoxyethylidene)malonate

Similarity: 0.71

Chemical Structure| 42466-67-1

[ 42466-67-1 ]

(E)-Ethyl 2-cyano-3-ethoxyacrylate

Similarity: 0.67

Chemical Structure| 94-05-3

[ 94-05-3 ]

Ethyl (ethoxymethylene)cyanoacetate

Similarity: 0.67

Chemical Structure| 3377-20-6

[ 3377-20-6 ]

Diethyl 2-methylenemalonate

Similarity: 0.64

Esters

Chemical Structure| 86971-83-7

[ 86971-83-7 ]

Methyl 3,4-Dihydro-2H-pyran-5-carboxylate

Similarity: 0.80

Chemical Structure| 87-13-8

[ 87-13-8 ]

Diethyl 2-(ethoxymethylene)malonate

Similarity: 0.80

Chemical Structure| 79725-98-7

[ 79725-98-7 ]

Pentadecyl 4-oxo-6-((palmitoyloxy)methyl)-4H-pyran-3-carboxylate

Similarity: 0.79

Chemical Structure| 36878-91-8

[ 36878-91-8 ]

Ethyl 3-(furan-3-yl)-3-oxopropanoate

Similarity: 0.75

Chemical Structure| 93097-22-4

[ 93097-22-4 ]

Ethyl 7-methoxy-4-oxo-4H-chromene-3-carboxylate

Similarity: 0.71

Ketones

Chemical Structure| 79725-98-7

[ 79725-98-7 ]

Pentadecyl 4-oxo-6-((palmitoyloxy)methyl)-4H-pyran-3-carboxylate

Similarity: 0.79

Chemical Structure| 36878-91-8

[ 36878-91-8 ]

Ethyl 3-(furan-3-yl)-3-oxopropanoate

Similarity: 0.75

Chemical Structure| 93097-22-4

[ 93097-22-4 ]

Ethyl 7-methoxy-4-oxo-4H-chromene-3-carboxylate

Similarity: 0.71

Chemical Structure| 4418-26-2

[ 4418-26-2 ]

Sodium 3-acetyl-6-methyl-2,4-dioxo-3,4-dihydro-2H-pyran-3-ide

Similarity: 0.66

Chemical Structure| 849762-24-9

[ 849762-24-9 ]

(3,6-Dioxocyclohexa-1,4-dien-1-yl)methyl 3-methylbutanoate

Similarity: 0.66